MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Frost & Sullivan
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Data Science to Accelerate Drug Discovery with Artificial Intelligence and Machine Learning Says Frost & Sullivan - Pharmaceutical companies and hospitals are adopting data science rapidly, and its application is going to be established in all branches of healthcare - Frost.com
Data Science to Accelerate Drug Discovery with Artificial Intelligence and Machine Learning Says Frost & Sullivan

 

NewswireToday - /newswire/ - Santa Clara, CA, United States, 2020/09/29 - Pharmaceutical companies and hospitals are adopting data science rapidly, and its application is going to be established in all branches of healthcare - Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Engineering / Artificial Intelligence Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Frost & Sullivan’s recent analysis, Data Science Impacting the Pharmaceutical Industry, finds that data science tools are promising technologies transforming drug discovery costs, speed, and efficiency. When combined with other emerging tech areas, artificial intelligence (AI) technologies move to the next phase of advancements. Hence, they are expected to witness adoption by pharma and biotech companies in the next four to five years. Further, with the COVID-19 pandemic, AI and machine learning (ML) can be used for drug research and clinical trials against the coronavirus to screen large databases and perform docking studies to identify existing potential drugs or design new drugs using advanced learning algorithms.

“Applying data science tools in healthcare, especially for drug discovery, has a huge potential to systematically change the entire existing practices and methods,” said Aarthi Janakiraman, Technical Insights Research Manager at Frost & Sullivan. “Additionally, pharmaceutical companies and hospitals are adopting this system rapidly, and its application is going to be established in all branches of healthcare.”

Janakiraman added: “Integrating AI and ML methods into drug discovery pipelines would cut down cost and time, and increase the efficiency of the entire research and development (R&D) process. Going forward, big pharma and mid-sized biotech companies can benefit by partnering with core AI startups and reducing the costs involved in setting up their own capabilities.”

Integrating data science in drug discovery and clinical trials presents immense growth prospects for market participants, including:

• Partnering with emerging AI companies will boost research momentum and help speed up clinical trials.
• Using AI for therapeutics and screening, including for COVID-19, as it provides access to a large library of compounds and can present a lower risk of unexpected toxicity or side effects in human trials.
• Developing AI-assisted drug safety and toxicity science that are at a nascent stage, yet evolving. This requires further research and collaborations to evaluate the potential clinical impact. Large amounts of newly available data provide an opportunity to leverage AI and ML to improve drug safety.
• Modernizing clinical trials as the FDA has created Master Clinical Trial Protocols (MAPs) to increase trial efficiency and lower costs. MAPs use common clinical trial infrastructure to streamline trial processes and enhance data collection.

Data Science Impacting the Pharmaceutical Industry is the latest addition to Frost & Sullivan’s Technical Insights research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For over five decades, Frost & Sullivan (frost.com) has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Data Science Impacting the Pharmaceutical Industry / D9B0

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Engineering / Artificial Intelligence Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Engineering / Artificial Intelligence articles,
CATCH Visitors via Your Competitors Announcements!


Data Science to Accelerate Drug Discovery with Artificial Intelligence and Machine Learning Says Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Mariana Fernandez - Frost.com 
210-348-1012 mariana.fernandez[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Engineering / Artificial Intelligence via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Engineering / Artificial Intelligence Most Recent Related Newswires:

Advanced Water Purification Technologies Promise to Deliver Clean and Safe Water to the Global Population Says Frost & Sullivan
Qualcomm Works to Support Chery JETOUR and Phoenix Auto Intelligence’s Advanced Digital Cockpit Experiences for Upcoming JETOUR Vehicles
Frost & Sullivan Recognizes Amelia, an IPsoft Company, with the 2020 North American Customer Value Leadership Award for its Conversational AI Platform
Nuance Awarded Frost & Sullivan’s 2020 Global Company of the Year Award for Leading the Conversational AI Market
Frost & Sullivan Examines Seven Virtual and Augmented Reality Application Areas Boosted by Global 5G Deployment
Thales and NEHS DIGITAL Join Forces on French Defence Ministry Project to Use AI to Fight COVID-19
Voith Successfully Commissions its First Virtual Reality Training System Worldwide At LEIPA with OnCall.Video
NEC OncoImmunity AS and Oslo University Hospital Team Up to Develop a Diagnostic for COVID-19 Using Artificial Intelligence
CGS Commended by Frost & Sullivan for its Introduction of Augmented Reality in an Immersive Customer Experience Solution, Teamwork AR™
Plus One Robotics Acclaimed by Frost & Sullivan for its Unique Approach to Human-Robot Collaboration in the Logistics Industry
Ultromics Lauded by Frost & Sullivan for Pioneering AI-based Cardiovascular Suite, EchoGo
SAP.iO Fund Invests in Neural-Based Search Company Jina AI
Evolv Applauded by Frost & Sullivan for Its Revenue-driving Customer Experience Optimization Technology
ABB Unveils Solutions to Accelerate Intelligent Manufacturing and Healthcare At China International Industry Fair
Helvar Commended by Frost & Sullivan for Leading the AI-powered Lighting Controls Market with its ActiveAhead Solution

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)